Angiogenesis in gastric cancer: Importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 61-65

  Han, Hye Seung ^a,b   Hwang, Tae Sook ^a  

^a Konkuk University Hospital   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Angiogenesis; Endothelial nitric oxide synthase; Gastric cancer; Immunohistochemistry; p53; Thymidine phosphorylase; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; PROTEIN P53; THYMIDINE PHOSPHORYLASE; TP53 PROTEIN, HUMAN; VASCULOTROPIN A;

ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH TUMOR; VASCULARIZATION;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; STOMACH NEOPLASMS; THYMIDINE PHOSPHORYLASE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34250718379     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.61     Document Type: Article

References (30)

1. Furukawa T, Yoshimura A, Sumizawa T, et al: Angiogenic factor. Nature 356: 668, 1992.
2. Miyazono K, Okabe T, Urabe A, Takaku F and Heldin CH: Purfication and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098-4103, 1987. (Pubitemid 17102635)
3. Ishikawa F, Miyazono K, Hellman U, et al: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989. (Pubitemid 19102308)
4. Miyadera K, Sumizawa T, Haraguchi M, et al: Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690, 1995.
5. Osaki M, Sakatani T, Okamoto E, Goto E, Adachi H and Ito H: Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas. Virchows Arch 437: 31-36, 2000. (Pubitemid 30446913)
6. Imazano Y, Takebayashi Y, Nishiyama K, et al: Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570-2578, 1997. (Pubitemid 27289887)
7. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K and Sumizawa T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996. (Pubitemid 26274605)
8. Shimaoka S, Matsushita S, Nitanda T, et al: The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma. Cancer 88: 2220-2227, 2000. (Pubitemid 30247120)
9. Kimura H, Konishi K, Nukui T, et al: Prognostic significance of expression of thymidine phosphorylase and vascular endothelial cell growth factor in human gastric carcinoma. J Surg Oncol 76: 31-36, 2001. (Pubitemid 32128360)
10. Giatromanolaki A, Koukourakis MI, Stathopoulos GP, et al: Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. Oncol Res 12: 33-41, 2000.
11. Noguchi T, Fujiwara S, Takeno S, et al : Clinical impact of thymidine phosphorylase expression in gastric cancer. Oncol Rep 10: 561-566, 2003.
12. Konno S, Takebayashi Y, Higashimoto M, et al: Thymidine phosphorylase expression in gastric carcinoma as a marker for metastasis. Anticancer Res 23: 5011-5014, 2003. (Pubitemid 38182118)
13. Hotta T, Taniguchi K, Kobayashi Y, et al: Increased expression of thymidine phosphorylase in tumor tissue in proportion to TP-expression in primary normal tissue. Oncol Rep 12: 539-541, 2004.
14. Koh EJ, Noh SH, Lee YD, et al: Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett 146: 173-180, 1999. (Pubitemid 29492887)
15. Kwon KM, Chu YC and Hwang TS: Expression of nitric oxide synthase isotypes in advanced gastric carcinoma. Korean J Pathol 36: 374-381, 2002.
16. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD and Ellis LM: Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2: 1679-1684, 1996. (Pubitemid 26356351)
17. Takahashi Y, Bucana CD, Akagi Y, et al: Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 4: 429-434, 1998. (Pubitemid 28122759)
18. Maeda K, Chung YS, Ogawa Y, et al: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996. (Pubitemid 26061277)
19. Tomoda M, Maehara Y, Kakeji Y, Ohno S, Ichiyoshi Y and Sugimachi K: Intratumoral neovascularization and growth pattern in early gastric carcinoma. Cancer 85: 2340-2346, 1999. (Pubitemid 29244841)
20. Dameron KN, Volpert OV, Tainsky MA and Bouck N: Control of angiogenesis fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994. (Pubitemid 24308973)
21. Omejc M, Juvan R, Jelenc F and Repse S: Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 86: 14-19, 2001. (Pubitemid 33594597)
22. Maeda K, Kang SM, Ogawa M, et al: Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74: 545-550, 1997. (Pubitemid 27486514)
23. Xiangming C, Hokita S, Natsugoe S, et al: Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 5: 585-589, 1998. (Pubitemid 28523245)
24. Araya M, Terashima M, Takagane A, et al: Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65: 232-236, 1997. (Pubitemid 27355848)
25. Sakatani T, Okamoto E, Tsujitani S, Ikeguchi M, Kaibara N and Ito H: Expressions of thymidine phosphorylase (dThdPase) and vascular endothelial growth factor on angiogenesis in intestinal-type gastric carcinoma. Oncol Rep 7: 831-836, 2000.
26. Yasuno M, Mori T, Koike M, et al: Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma. Oncol Rep 13: 405-412, 2005.
27. Tsujitani S, Saito H, Maeta Y, et al: Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase. Anticancer Res 24: 1853-1859, 2004. (Pubitemid 38954599)
28. Koide N, Nashio A, Hiraguri M, et al: Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus. Dis Esophagus 15: 67-73, 2002. (Pubitemid 34812002)
29. Doi C, Noguchi Y, Marat D, et al: Expression of nitric oxide synthase in gastric cancer. Cancer Lett 144: 161-167, 1999. (Pubitemid 29457658)
30. Vindigni C, Miracco C, Spina D, et al: Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type. Int J Cancer 74: 637-641, 1997. (Pubitemid 28037508)